INSP(Inspire Medical Systems, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $233.39M | $407.86M | $624.80M | $802.80M | $911.98M |
| 毛利润 | $200.12M | $341.74M | $528.22M | $679.82M | $778.76M |
| 营业利润 | −$39.85M | −$47.59M | −$40.27M | $36.08M | $50.95M |
| 净利润 | −$42.04M | −$44.88M | −$21.15M | $53.51M | $145.42M |
| 经营现金流 | −$20.12M | $11.57M | $24.65M | $130.25M | $116.98M |
| 自由现金流 | −$24.79M | $2.47M | $1.02M | $91.12M | $78.48M |
| 摊薄每股收益 | $-1.54 | $-1.60 | $-0.72 | $1.75 | $4.89 |